4.6 Article

Comprehensive Analysis of Clinical Trials Registration for Lupus Nephritis Therapy on ClinicalTrials.gov

Related references

Note: Only part of the references are listed.
Review Pediatrics

Kidney outcomes for children with lupus nephritis

Louise Oni et al.

Summary: Juvenile-onset systemic lupus erythematosus is more aggressive than adult-onset disease, with over 50% of children experiencing kidney involvement. Treatment protocols involve intense immunosuppression followed by maintenance therapy, but achieving complete kidney remission remains a challenge. Future research should focus on early disease biomarkers and evaluating biologic agents to improve outcomes.

PEDIATRIC NEPHROLOGY (2021)

Review Urology & Nephrology

The Evolving Role of Calcineurin Inhibitors in Treating Lupus Nephritis

Yonatan Peleg et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)

Article Pharmacology & Pharmacy

Comprehensive Survey of Clinical Trials Registration for Melanoma Immunotherapy in the ClinicalTrials.gov

Yan-Bo Wang et al.

FRONTIERS IN PHARMACOLOGY (2020)

Article Medicine, Research & Experimental

Evaluation of the inhibitory effect of tacrolimus combined with mycophenolate mofetil on mesangial cell proliferation based on the cell cycle

Yanfang Gao et al.

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2020)

Article Rheumatology

Lupus nephritis: clinical presentations and outcomes in the 21st century

Michela Gasparotto et al.

RHEUMATOLOGY (2020)

Article Chemistry, Medicinal

Clinical efficacy and safety of rituximab in lupus nephritis

Zhiqing Zhong et al.

DRUG DESIGN DEVELOPMENT AND THERAPY (2019)

Article Urology & Nephrology

Autologous Hematopoietic Stem Cell Transplantation for Refractory Lupus Nephritis

Xianghua Huang et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)

Article Pharmacology & Pharmacy

Clinical Trial Registration and Reporting: Drug Therapy and Prevention of Cardiac-Related Infections

Lin-Lu Ma et al.

FRONTIERS IN PHARMACOLOGY (2019)

Article Urology & Nephrology

Membranous Lupus Nephritis: A Clinical Review

Salem Almaani et al.

ADVANCES IN CHRONIC KIDNEY DISEASE (2019)

Article Urology & Nephrology

Moving Forward With Biologics in Lupus Nephritis

Liliane Hobeika et al.

ADVANCES IN CHRONIC KIDNEY DISEASE (2019)

Article Rheumatology

Calcineurin inhibitors in systemic lupus erythematosus

Chi Chiu Mok

BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2017)

Review Rheumatology

New insights into the immunopathogenesis of systemic lupus erythematosus

George C. Tsokos et al.

NATURE REVIEWS RHEUMATOLOGY (2016)

Review Rheumatology

Towards new avenues in the management of lupus glomerulonephritis

C. C. Mok

NATURE REVIEWS RHEUMATOLOGY (2016)

Article Transplantation

Con: The use of calcineurin inhibitors in the treatment of lupus nephritis

Maria Fernandez Nieto et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2016)

Review Anesthesiology

Clinical Research Methodology 3: Randomized Controlled Trials

Daniel I. Sessler et al.

ANESTHESIA AND ANALGESIA (2015)

Review Cardiac & Cardiovascular Systems

Multicenter trials, guidelines, and uncertainties - Do we know as much as we think we do?

James M. Brophy

INTERNATIONAL JOURNAL OF CARDIOLOGY (2015)

Review Cardiac & Cardiovascular Systems

Design of Major Randomized Trials Part 3 of a 4-Part Series on Statistics for Clinical Trials

Stuart J. Pocock et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)

Article Urology & Nephrology

Renal Flare as a Predictor of Incident and Progressive CKD in Patients with Lupus Nephritis

Samir V. Parikh et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)

Editorial Material Medicine, General & Internal

Minimizing Bias in Randomized Trials The Importance of Blinding

Bruce M. Psaty et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)

Article Medicine, General & Internal

Blinding in randomised trials: hiding who got what

KF Schulz et al.

LANCET (2002)